Previous Article | Next Article 
Infection and Immunity, November 2001, p. 6651-6659, Vol. 69, No. 11
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.6651-6659.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Critical Role for Tumor Necrosis Factor Alpha in
Controlling the Number of Lumenal Pathogenic Bacteria and
Immunopathology in Infectious Colitis
Nathalie S.
Gonçalves,1
Marjan
Ghaem-Maghami,2
Giovanni
Monteleone,1
Gad
Frankel,2
Gordon
Dougan,2
David J. M.
Lewis,3
Cameron P.
Simmons,2 and
Thomas T.
MacDonald1,*
School of Medicine, University of
Southampton, Southampton General Hospital, Southampton SO16
6YD,1 Centre for Molecular Microbiology
and Infection, Department of Biochemistry, Imperial College of Science,
Technology, and Medicine, London SW7 2AZ,2 and
St. George's Hospital Medical School, London SW17
0RE,3 United Kingdom
Received 19 March 2001/Returned for modification 18 May
2001/Accepted 10 August 2001
 |
ABSTRACT |
Infection of mice with the intestinal bacterial pathogen
Citrobacter rodentium results in colonic mucosal
hyperplasia and a local Th1 inflammatory response similar to that seen
in mouse models of inflammatory bowel disease. In these latter models, and in patients with Crohn's disease, neutralization of tumor necrosis
factor alpha (TNF-
) is of therapeutic benefit. Since there is no
information on the role of TNF-
in either immunity to noninvasive
bacterial pathogens or on the role of TNF-
in the immunopathology of
infectious colitis, we investigated C. rodentium
infection in TNFRp55
/
mice. In TNFRp55
/
mice, there were higher colonic bacterial burdens, but the organisms were cleared at the same rate as C57BL/6 mice, showing that
TNF-
is not needed for protective antibacterial immunity. The
most striking feature of infection in TNFRp55
/
mice, however, was the markedly enhanced pathology, with
increased mucosal weight and thickness, increased T-cell infiltrate,
and a markedly greater mucosal Th1 response. Interleukin-12 p40
transcripts were markedly elevated in C.
rodentium-infected TNFRp55
/
mice, and this was
associated with enhanced mucosal STAT4 phosphorylation. TNF-
is not
obligatory for protective immunity to C. rodentium in
mice; however, it appears to play some role in downregulating mucosal
pathology and Th1 immune responses.
 |
INTRODUCTION |
There is now little doubt that
increased local concentrations of tumor necrosis factor alpha (TNF-
)
are of prime importance in driving chronic inflammation in a number of
tissues (26, 34, 51, 58, 60). In particular, in the
intestine, excess TNF-
is associated with pathology
(56). It is likely that excess local TNF-
can drive
tissue injury via a number of pathways, including direct effects on
epithelial function and permeability (16, 18, 43),
upregulation of adhesion molecule expression on endothelium
(4), increased production of chemokines by various cell
types (33), and upregulation of matrix-degrading enzyme production by stromal cells (45). In mouse models of
inflammatory bowel disease (IBD) (41, 46) and Crohn's
disease in patients, neutralization of TNF-
has a clear therapeutic
effect (52, 57). TNFRp55 knockout mice are resistant to
experimental colitis (41), and mice overexpressing TNF-
are more susceptible to experimental colitis (41) and
indeed may spontaneously develop ileitis (27). In these
mouse models and probably in Crohn's disease as well, the mucosal
T-cell immune response which results in the inflammatory cell
infiltrate and excess TNF-
production is directed against the normal
bacterial flora (12). Support for the general notion that
immune responses against lumenal organisms can cause tissue injury via
excess TNF-
production also comes from studies on the protozoan
parasite Toxoplasma gondii (31). In certain
strains of mice, infection leads to hemorrhagic necrosis of the
intestine (31). This severe response, which results in the
death of the host, can be ameliorated by blocking TNF-
(30).
To our knowledge, there are only two murine systems wherein it is
possible to set up a natural noninvasive bacterial infection in mouse
intestine which mimics human disease. These are Helicobacter pylori or Helicobacter felis in the murine stomach
(28, 36) and Citrobacter rodentium infection of
the colon (19). Helicobacter elicits a pronounced
Th1 response in the stomach which drives the pathology (9,
39), but there have been no studies yet on the role of TNF-
in this model.
C. rodentium is a natural pathogen of mice. It has many
similarities to human enteropathogenic Escherichia
coli (EPEC) or enterohemorrhagic E. coli (EHEC)
infection (29). EPEC, EHEC, and C. rodentium
colonize the intestinal mucosa and, by subverting intestinal epithelial
cell cytoskeleton function, produce a characteristic histopathological
feature known as the "attaching and effacing " (A/E) lesion
(11). This requires a number of bacterial factors, including EPEC-secreted proteins (Esps), a type III secretory apparatus, and an outer membrane protein called intimin. Significant progress has been made defining the molecular basis of EPEC-host cell
interactions and defining the role of EPEC's virulence determinants in
the regulation of host cell cytoskeletal rearrangement
(55). Not surprisingly, however, in vitro studies with
epithelial cell cultures can only model the intestinal epithelium in a
limited fashion and provide little insight into host immune responses. Indeed, the type and magnitude of the immune response in animals or
humans infected with enteric bacterial pathogens that colonize via A/E
lesion formation has been poorly described. In part, this is due to the
difficulty in studying immune responses in EPEC- or EHEC-infected
humans (usually children) or large animals. Nevertheless, a better
understanding of these facets of the host-pathogen interaction could
speed the design of vaccines and immune-based therapies which can
prevent diarrhea.
In several respects, C. rodentium infection of mice
represents the best small-animal model in which to study host defense against lumenal microbial pathogens relying on A/E lesion formation for
colonization of the host. C. rodentium possesses both
established and putative virulence determinants common to EPEC and EHEC
(50), including the LEE pathogenicity island
(38) and lymphostatin toxin (25). The A/E
lesion induced by C. rodentium is ultrastructurally identical to those formed by EHEC and EPEC in animals and humans (10, 47). In naturally or experimentally infected
susceptible mouse strains, large numbers of C. rodentium can
be recovered from the colon, and infection is associated with crypt
hyperplasia, goblet cell depletion, and mucosal erosion (3,
23). Extraintestinal infection of immunocompetent mice is rarely
seen. Oral infection of mice with live C. rodentium or
intracolonic inoculation of dead bacteria induces a
CD3+ and CD4+ T-cell
infiltrate into the colonic lamina propria and a highly polarized Th1
response (19, 20). Transcripts for the cytokines interleukin-12 (IL-12), TNF-
, and gamma interferon (IFN-
) are highly expressed in colonic tissue of infected mice. The role of these
cytokines in host defense and mucosal pathology is unknown.
One striking feature of C. rodentium infection is that the
T-cell response and pathology in the colon are virtually identical to
that seen in mouse models of IBD (19). Given the crucial role of TNF-
in these models, it is logical to investigate the role
of TNF-
in C. rodentium infection. Here we report, in
contrast to all other systems studied before, that the absence of
TNF-
is not associated with less inflammation in C. rodentium infection. TNFRp55 knockout mice develop more severe
pathology. This is associated with an increase in IL-12, Stat4
activation, an exaggerated local Th1 response, and increased bacterial
loads in the gut, although these are eventually cleared.
 |
MATERIALS AND METHODS |
Animals.
Female or male 6- to 8-week-old C57BL/6J mice were
purchased from Harlan Olac (Bichester, United Kingdom) or B&K Universal (Hull, United Kingdom). TNFRp55
/
mice
(backcrossed to a C57BL/6 background at least 10 times) were originally
purchased from Jackson Laboratories and were maintained by homozygous
mating under contract at B&K Universal. The presence (in the case of
C57BL/6 mice) or absence (in the case of
TNFRp55
/
mice) of the TNF receptor type I p55
was analyzed by Western blotting and confirmed the genotyping (data not
shown). All mice came from colonies which were specific pathogen-free.
During experimental studies, groups of animals were housed in
HEPA-filtered individually ventilated cages with free access to
sterilized food and water. Mice were checked daily and weighed at the
start and during each experiment.
Bacterial strain and challenge of mice.
DBS255(pCVD438) is a
C. rodentium eae mutant complemented with the eae
gene from EPEC strain E2348/69 (intimin
). This strain, which has
been described previously (17, 20), expresses biologically active intimin, and is virulent in mice. Bacterial inocula were prepared by culturing bacteria overnight at 37°C in L broth
containing nalidixic acid (100 µg/ml) plus chloramphenicol (50 µg/ml). Cultures were harvested by centrifugation and resuspended in
a 1/10 volume of phosphate-buffered saline (PBS). Mice were orally
inoculated by using a gavage needle with 2 × 109 to 3 × 109 CFU of
bacteria in 200 µl of PBS. The viable count of the inoculum was
determined by retrospective plating on L agar containing appropriate antibiotics. At selected time points postinfection, mice were killed by
cardiac exsanguination under terminal anesthesia or by cervical
dislocation. The terminal 6 cm of the colon was removed, and the colon
was weighed after the removal of fecal pellets. In some experiments,
the distal 1 cm of the colon was snap frozen in liquid nitrogen for
subsequent analysis. The spleen, mesenteric lymph nodes (MLN),
and remaining colon were removed and homogenized mechanically by using
a Seward 80 stomacher (London, England). The number of viable bacteria
in organ homogenates was determined by viable count on L agar
containing nalidixic acid and chloramphenicol. The lower limit of
sensitivity of the bacteria was 10 CFU per organ.
Immunohistochemistry.
Three-step avidin-peroxidase staining
was performed on 5-µm frozen sections as described previously
(59) with the monoclonal antibodies 145-2C11 (anti-CD3),
YTS191 (anti-CD4), YTS169 (anti-CD8), and M5-114 (anti-major
histocompatibility complex class II). Biotin-conjugated rabbit anti-rat
immunoglobulin G (IgG) (Dako, High Wycombe, United Kingdom) and goat
anti-hamster IgG (Vector Laboratories, Peterborough, United Kingdom)
were used at 1:50 dilution in Tris-buffered saline (TBS; pH 7.6)
containing 4% (vol/vol) normal mouse serum (Harlan Seralab, Oxon,
United Kingdom). Avidin-peroxidase (Sigma) was used at a dilution of
1:200 in TBS. A two-step protocol was performed with rabbit
anti-intimin antibody as described before (1), together
with horseradish peroxidase (HRP)-conjugated swine anti-rabbit IgG
secondary antibody. As controls for the specificity of the staining,
serial sections were processed omitting the primary antibody or,
alternatively, by using rabbit IgG (5 µg/ml; Sigma) as the first-step
antibody. In both cases, no staining was observed. Peroxidase activity
was detected with 3,3'-diaminobenzidine tetrahydrochloride (DAB; Sigma)
in a 0.5-mg/ml solution of Tris-HCl (pH 7.6) containing 0.01%
H2O2. The density of
positive cells in the lamina propria was determined by image analysis.
Crypt length was measured by micrometry on
hematoxylin-and-eosin-stained sections, with 10 measurements being
taken in the distal colons of individual mice. Only well-orientated
crypts were counted. Also, we quantified the bacteria in the glands by
counting 100 glands and recording how many were positive for intimin
staining. The data were expressed as a percentage.
RNA extraction and quantitative RT-PCR.
Total cellular RNA
was isolated from frozen distal colonic tissue by homogenization of the
tissue in TRIzol (Gibco/Life Technologies, Pailsey, United Kingdom) and
incubation at room temperature for 5 min. RNA was extracted with
chloroform (Sigma) and then centrifuged for 15 min at 12,000 × g at 4°C. The pellet was washed with 70% ethanol and
resuspended in 50 µl of water. Total RNA was measured by
spectrophotometric analysis. Constructs encoding standard RNAs (pCMQ1,
pCMQ2, pCMQ3, and pCMQ4), kindly provided by M. F. Kagnoff, Department of Medicine, University of California, San Diego
(13), were used for quantitative competitive reverse
transcription-PCR (RT-PCR). pCMQ1 contains primer sites for IFN-
;
pCMQ2 contains primer sites for IL-4, and TNF-
; and pCMQ3 carries
primer sites for IL-12 p40. To generate standard RNA, plasmids were
linearized with SalI (pCMQ1), NotI (pCMQ2, pCMQ3,
and pCMQ4) and transcribed in vitro with T7 RNA polymerase under
conditions recommended by the supplier (Promega, Southampton, United
Kingdom). Serial 10-fold dilutions of standard RNA (1 pg to 1 fg) were
co-reverse transcribed with total cellular RNA (1 µg) at 42°C for
50 min in a 20-µl reaction volume containing 50 mM Tris (pH 8.3), 75 mM KCl, 3 mM MgCl2, 3 mM dithiothreitol, a 10 mM
deoxynucleoside triphosphate mix, and 0.5 µg of oligo(dT) (Pharmacia
Biotech, St. Albans, Hertfordshire, United Kingdom), using 100 U of
reverse transcriptase (Superscript II; RNase H negative; Gibco). The
reaction was terminated by heat inactivation at 70°C for 10 min. PCR
amplification was routinely carried out in a 50-µl reaction volume
(10 mM Tris, pH 9; 50 mM KCl; 1.5 mM MgCl2; 200 µM concentrations of each deoxynucleoside triphosphate; and 20 pmol
of specific 5' and 3' primers), using 1 U of Taq polymerase
(Pharmacia Biotech). The temperature profile of the amplification
consisted of 35 cycles of 45 s of denaturation at 94°C, 1 min
15 s of annealing at 58°C, and 1 min 15 s of extension at
72°C. PCR products were then separated on a 1% agarose gel and
visualized by ethidium bromide staining on a UV transilluminator. Band
intensities were quantified by densitometry (Seescan, Cambridge, United
Kingdom). The ratios of the band intensities of the PCR products from
the standard RNA and target RNA were plotted against the starting
number of standard RNA molecules by using a double-logarithmic scale.
When the ratio of the band intensities equals 1, the number of target
RNA molecules is equivalent to the number of standard RNA molecules.
Data are expressed as the number of target RNA molecules/microgram of
total sample RNA. The quantitative RT-PCR was sensitive to
103 cytokine mRNA transcripts per µg of total RNA.
Immunoprecipitation and Western blot analysis.
Colonic
tissue samples were lysed on ice in 300 µl of lysis buffer containing
0.0625 mol of Tris (pH 6.8)/liter, 2% sodium dodecyl sulfate (SDS),
3%
-mercaptoethanol, 10% glycerol, 100 mmol of sodium
fluoride/liter, 10 µg of aprotinin/ml, 10 µg of leupeptin/ml, and 1 mmol of phenylmethylsulfonyl fluoride/liter. The tissue was then
homogenized by passage through a 21-gauge needle. The lysates were then
centrifuged at 4,000 × g for 30 min at 4°C. The
resulting supernatants were collected and stored at
80°C prior to
analysis. The protein content was determined by using the Bio-Rad assay
(Bio-Rad Laboratories, Hercules, Calif.). Total proteins (750 µg/sample) were incubated with anti-Stat4 (Santa Cruz Biotechnology,
Santa Cruz, Calif.) at 4°C for 2 h. Immune complexes were
collected by incubation with protein A/G agarose (20 µl/sample)
(Santa Cruz Biotechnology), washed three times with lysis buffer, and
heated for 5 min in a boiling water bath in sample buffer for
SDS-polyacrylamide gel electrophoresis. Immunoprecipitates from
extracts containing the same amount of protein were analyzed by Western
blotting by using antibody against phosphotyrosine (p-Tyr) (1:1,000
final dilution; Santa Cruz Biotechnology), followed by a HRP-conjugated
goat anti-mouse IgG monoclonal antibody (1:10,000 dilution; Dako).
Reactivity was detected by a chemiluminescence kit (Amersham
International). After the analysis of phosphorylated Stat4, blots were
stripped by incubation for 30 min at 50°C in stripping medium (2%
SDS, 0.05 M Tris, 0.1 M
-mercaptoethanol) and then incubated with
antibody against Stat4 (Santa Cruz Biotechnology), followed by an
HRP-conjugated goat anti-rabbit IgG antibody (1:2,500 dilution; Dako).
Antibody reactivity was again developed by using chemiluminescence
(Amersham International). As a positive control, peripheral blood
mononuclear cells were extracted from healthy volunteers, resuspended
in RPMI 1640 containing 10% fetal calf serum, and incubated with
phytohemagglutinin (PHA) (1 µg/ml) overnight. The next day,
the nonadherent cells were collected, washed once with PBS, and then
stimulated with 5 ng of IL-12/ml for 1 h. Both p-Stat4 and total
Stat4 were analyzed as previously described (44).
Statistical analysis.
The data are presented as the
mean ± the standard error of the mean (SEM) and were analyzed by
the Student's t test. P values of <0.05 were
considered significant.
 |
RESULTS |
Bacterial burden in the colon of C.
rodentium-infected TNFRp55
/
mice.
Age-matched female C57BL/6 and
TNFRp55
/
mice were infected with
the DBS255(pCVD438) C. rodentium strain and killed on days 7, 14, and 21 postinfection. Infected and uninfected C57BL/6 and TNFRp55
/
mice showed similar weight gains. As
expected, bacteria were recovered from the colon at day 7 (Fig.
1A) in infected C57BL/6 and TNFRp55
/
mice; however, there was a
greater number in the TNFRp55
/
mice which
nearly achieved statistical significance (P = 0.06). At day 14, the colons of infected
TNFRp55
/
mice showed a
statistically significant 2-log increase in bacterial load compared to
infected C57BL/6 mice (Fig. 1A, P = 0.006). Only small
numbers of live bacteria were recovered from the MLN and spleens during
the course of infection, but these were higher in the
TNFRp55
/
mice (Fig. 1B and C). The presence
of bacteria adhering to the epithelial surface was visualized by
immunohistochemistry with anti-intimin antibody. In the infected
C57BL/6 mice, bacteria were visualized on the surface of the epithelial
cells facing the gut lumen (Fig. 2).
Strikingly, in TNFRp55
/
mice, bacteria were
present on the surface epithelium but were occasionally seen deep in
the glands (Fig. 2). For example, in C57BL/6 mice at day 7, no
mice showed bacteria deep in the glands; however, in
TNFRp55
/
mice at the same time
point, 4 of 6 mice showed bacteria at this site (5, 13, 14, and 15% of
glands). Another striking feature was that the anti-intimin antibody,
in addition to staining the bacteria, also stained epithelial cells
underlying areas of bacterial colonization (Fig. 2).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 1.
Bacterial load in C.
rodentium-infected C57BL/6 and TNFRp55 /
mice. Bacterial counts were determined in the colon (A), spleen
(B), and MLN (C) at the indicated time points. Each point reflects the
means and SEM (error bars) of five mice per group ( ,
P < 0.05). The data shown are from one experiment
of three, which yielded identical results. The lower limit detection of
the bacteria is 10 CFU per organ.
|
|

View larger version (141K):
[in this window]
[in a new window]
|
FIG. 2.
Intimin staining of C. rodentium-infected
C57BL/6 mice (magnifications: A, ×100; C, ×1,000; F, ×400) and
TNFRp55 / mice (magnifications: B, ×100; D, ×1,000).
(D) Bacteria can be seen along the surface epithelium in both groups of
mice (arrows) and occasionally deep in the glands in the infected
TNFRp55 / mice. (E) Rabbit isotype control IgG showed no
staining (magnification, ×400). Another feature was that the
anti-intimin antibody, in addition to staining the bacteria, also
stained epithelial cells underlying areas of bacterial colonization (D,
large arrows).
|
|
Colonic mucosal hyperplasia.
TNFRp55
/
C. rodentium-infected
mice showed increased colonic weight compared to infected wild-type
mice (Fig. 3A). This was associated with
increased mucosal hyperplasia (Fig. 3B).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Weight of the distal colon (A) and crypt length (B) in
uninfected and C. rodentium-infected C57BL/6 and
TNFRp55 / mice on days 7 and 14. Each group contained
five mice ( , P < 0.05).
|
|
Evidence for immune dysregulation in TNFRp55
/
infected with C. rodentium
We next investigated
the T-cell infiltrate and mRNA expression of regulatory cytokines.
Immunohistology of the colon at day 14 postinfection revealed that
there were approximately twice as many CD3+ cells present
in the lamina propria of TNFRp55
/
-infected mice
compared to the C57BL/6 mice (Fig. 4A).
Similar changes in the number of CD4+ cells (Fig. 4B) were
seen. CD8+ cells (Fig. 4C) were also increased compared to
noninfected mice, but no difference was seen between the infected
TNFRp55
/
mice and the infected C57BL/6 mice. Infected
TNFRp55
/
mice showed a striking increase in IFN-
mRNA transcripts (Fig. 5A) and IL-12p40
mRNA transcripts (Fig. 5B) at day 14 compared to infected C57BL/6 mice.
TNF-
transcripts (Fig. 5C) were also increased, but no difference
was seen between infected C57BL/6 and TNFRp55
/
mice.
IL-4 mRNA did not significantly differ from uninfected controls at any
time (Fig. 5D). Taken together, these data showed that the pronounced
immunopathology in the infected TNFRp55
/
mice is linked
to an exaggerated Th1 response in the lamina propria.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Cell counts for CD3+ (A), CD4+
(B), and CD8+ (C) cells infiltrating the lamina propria in
uninfected and C. rodentium-infected C57BL/6 and
TNFRp55 / mice on days 7 and 14. Each group represents
five mice (the mean ± SEM) ( , P < 0.05).
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Cytokine mRNA transcripts in gut tissue of uninfected
and C. rodentium-infected C57BL/6 and
TNFRp55 / mice on days 7 and 14. Each group represents
five mice (the mean ± SEM; , P < 0.05).
(A) IFN- . (B) IL-12p40. (C) TNF- . (D) IL-4.
|
|
Stat4 activation.
Stat4 is a key molecule in the intracellular
signal transduction cascade activated in response to IL-12 stimulation.
It is phosphorylated in response to IL-12 receptor ligation, resulting in the translocation of Stat4 to the nucleus and transactivation of
genes that promote Th1 differentiation. An increase in the expression
of phosphorylated Stat4 was seen in infected C57BL/6 mice, but this was
even more enhanced in the TNFRp55
/
mice (Fig.
6).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 6.
Western blot analysis of Stat4 and
tyrosine-phosphorylated Stat4 in the gut tissue of uninfected and
C. rodentium-infected C57BL/6 and
TNFRp55 / mice on day 14. Three mice per group were
analyzed in each of two independent experiments, and representative
autoradiograph is shown in panel A. An increase in p-Stat4 expression
was seen in the infected TNFRp55 / mice at day 14. (B)
The density of the bands was also quantified. In total, we analyzed 5 to 6 mice per group. As positive control (+ve), we used
proteins extracted from human peripheral blood mononuclear cells
preactivated with PHA and then stimulated with IL-12, the major
Stat4-inducing cytokine.
|
|
 |
DISCUSSION |
In the present study, we have shown for the first time that
TNF-
plays a role in controlling pathogenic bacterial populations in
the gut and preventing tissue injury. We demonstrated that infection of
TNFRp55
/
mice with C. rodentium
resulted in more severe gut injury and pathology than in infected
C57BL/6 control mice, but after 21 days the pathology resolved and the
bacteria were cleared. More bacteria were also recovered in the colon
and systemic tissues of infected TNFRp55
/
mice. Finally, there was a striking increase in IL-12p40 and IFN-
mRNA transcripts in the C. rodentium-infected
TNFRp55
/
mice.
It was unexpected that TNFRp55
/
mice would
show increased lumenal bacterial burdens. One reason may be that
TNF-
is involved in controlling the numbers of bacteria which
initially colonize the gut by regulating innate immunity. In the lung
and peritoneum, TNF-
produced by mast cells has been implicated in
early host defenses against bacterial infections (35). The
mechanism of early protection appears to be due to a mast cell-derived
TNF-
-mediated emigration of neutrophils from the blood
(35). However, the epithelial barrier and the low numbers
of bacteria that actually colonize the epithelial surface early in
infection means that early interactions with mucosal mast cells are not
likely early in the case of C. rodentium infection. A more
relevant cell in the context of early immunity in the gut could be the
epithelial cell. Stimulation of human intestinal colonic epithelial
cell lines with invasive strains of bacteria causes the increased
secretion of chemoattractant and proinflammatory cytokines such as IL-8 and TNF-
(24). Proinflammatory cytokines can also be
activated in uroepithelial cells after interaction with a noninvasive
uropathogenic E. coli (40) and in human gut
epithelial cell lines after infection with EPEC (49).
Epithelial cells within the human stomach can also interact with the
noninvasive bacterial pathogen, H. pylori, leading to
upregulation of IL-8 gene expression in the apparent absence of
bacterial entry (6). TNF-
could then amplify the early
inflammatory response by attracting and activating neutrophils, macrophages, and eosinophils (8, 14). The inflammatory
cells could then produce increased epithelial permeability, and
antibacterial proteins in serum could act locally on the epithelial
cell surface. Another potential defense mechanism could involve
antimicrobial peptides, such as defensins. With the recent evidence for
epithelial expression of human neutrophil defensins 1, 2, and 3 in IBD
(7) and upregulation of
defensins in intestinal
epithelial cells by proinflammatory cytokines (42, 53), an
autocrine loop involving epithelial-cell-derived TNF acting on adjacent
epithelial cells to upregulate defensin-mediated intestinal
antimicrobial immunity is a possibility.
An alternative explanation for enhanced bacterial load is that it is
secondary to the epithelial hyperplasia, which itself is secondary to
the enhanced Th1 response we documented (although there is the
possibility that it is the increased bacterial load per se that elicits
the greater Th1 response). Since the bacteria colonize the surface of
the mucosa, the increased surface area in the
TNFRp55
/
mice could be responsible for the
increase in colonic bacterial burden. It was also noteworthy that in
the TNFRp55
/
mice the bacteria invaded the
glands. This will contribute to the overall bacterial burden, but the
reason for this is unknown. Strikingly, in areas of bacterial
colonization, there was also intimin staining of epithelial cells
underlying the bacteria. This strongly suggests that intimin is
internalized in the epithelial cells in vivo, and this phenomenon is
currently under investigation.
IL-12 is an immunoregulatory cytokine that plays a central role in the
control of Th1 immune response and has been shown to induce the
production of inflammatory cytokines such as IFN-
and TNF-
(54). STATs (signal transducers and activators of transcription) are involved in the signal transduction cascades of many
cytokines (22). Phosphorylated Stat4 was increased
in the colon of C. rodentium infected
TNFRp55
/
mice. The enhanced Th1
response could therefore lead to an increase in inflammation in the
mucosa of the TNFRp55
/
mice, and indeed there
were increased numbers of mucosal T cells in these mice. The link
between stronger Th1 responses and epithelial hyperplasia may involve
keratinocyte growth factor (KGF) production by fibroblasts, which is
upregulated by proinflammatory cytokines such as IL-1
and TNF-
(5). KGF (FGF-7) is a member of the fibroblast growth
factor family, is secreted by stromal cells, and plays a role in the
continuous renewal of the intestinal epithelium (15).
Studies in our laboratory have suggested a role for KGF in mediating
crypt hyperplasia in coeliac disease (48), and in a model
system we have also shown that KGF is involved in T-cell-driven crypt
cell hyperplasia (2). The mechanisms involved in C. rodentium mucosal hyperplasia are currently under investigation,
and the factors overexpressed in the thickened mucosa of
TNFRp55
/
mice provide an ideal tool
for investigating this problem.
There are other data to suggest that TNF-
directly inhibits IL-12
production, which would support the notion that it is the direct
absence of TNF-
which results in higher IL-12 levels. It was
recently shown that IL-12 production in thioglycolate-elicited mouse
macrophages could be suppressed by TNF-
and that TNF-
-deficient mice developed a delayed but vigorous inflammatory response to heat-killed Corynebacterium parvum with very high levels of
IL-12 in serum (21, 37). The reduced inflammation of
Corynebacterium parvum-injected wild-type mice with lower
IL-12 production suggested that TNF-
might play a role in limiting
and reversing inflammation and tissue injury. Another study has also
shown that TNF-
can downregulate the IL-12-dependent Th1 response
during bacterial infections (32).
In conclusion, we show for the first time that TNF-
may play a role
in controlling bacterial populations on the surface of the gut
epithelium. Whether the enhanced immunopathology is primary or
secondary to the enhanced bacterial burdens is currently under investigation.
 |
ACKNOWLEDGMENTS |
This study was supported by the European Union Training and
Mobility of Researchers Programme (ERBFMRXCT9) and by the Wellcome Trust. N.S.G. was supported by the Crohn's in Childhood Research Association (CICRA).
N.S.G. and M.G.-M. contributed equally to this work.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Infection, Inflammation and Repair, School of Medicine, University of
Southampton, Mail Point 813, Level E, South Block, Southampton General
Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom.
Phone: 02380-794754. Fax: 02380-796604. E-mail:
t.t.macdonald{at}soton.ac.uk.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Adu-Robie, J.,
G. Frankel,
C. Bain,
A. G. Gonçalves,
L. R. Trabulsi,
G. Douce,
S. Knutton, and G. Dougan.
1998.
Detection of intimins , , , and , four intimin derivatives expressed by attaching and effacing microbial pathogens.
J. Clin. Microbiol.
36:662-668[Abstract/Free Full Text].
|
| 2.
|
Bajaj-Elliott, M.,
R. Poulsom,
S. L. F. Pender,
N. C. Wathen, and T. T. MacDonald.
1998.
Interaction between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia.
J. Clin. Investig.
102:1473-1480[Medline].
|
| 3.
|
Barthold, S. W.
1980.
The microbiology of transmissible murine colonic hyperplasia.
Lab. Anim. Sci.
30:167-173[Medline].
|
| 4.
|
Binion, D. G.,
G. A. West,
K. Ina,
N. P. Ziats,
S. N. Emancipator, and C. Fiocchi.
1997.
Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease.
Gastroenterology
112:1895-1907[CrossRef][Medline].
|
| 5.
|
Chedid, M.,
J. S. Rubin,
K. G. Csaky, and S. A. Aaronson.
1994.
Regulation of keratinocyte growth factor gene expression by interleukin 1.
J. Biol. Chem.
269:10753-10757[Abstract/Free Full Text].
|
| 6.
|
Crowe, S. E.,
L. Alvarez,
M. Dytoc,
R. H. Hunt,
M. Muller,
P. Sherman,
J. Patel,
Y. Jin, and P. B. Ernst.
1995.
Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro.
Gastroenterology
108:65-74[CrossRef][Medline].
|
| 7.
|
Cunliffe, R. N.,
F. R. A. J. Rose,
P. D. James, and Y. R. Mahida.
1999.
Expression of antimicrobial neutrophil defensin and lysozyme is induced in epithelial cells of active inflammatory bowel disease (IBD) mucosa.
Gastroenterology
116:G3936.
|
| 8.
|
Danis, V. A.,
G. M. Franic,
D. A. Rathjen, and P. M. Brooks.
1991.
Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN- ), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes.
Clin. Exp. Immunol.
85:143-150[Medline].
|
| 9.
|
D'Elios, M. M.,
M. Manghetti,
M. De Carli,
F. Costa,
C. T. Baldari,
D. Burroni, and J. L. Telford.
1997.
T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease.
J. Immunol.
158:962-967[Abstract].
|
| 10.
|
Donnenberg, M. S.,
C. O. Tacket,
S. P. James,
G. Losonsky,
J. P. Nataro,
S. S. Wasserman,
J. B. Kaper, and M. M. Levine.
1993.
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
J. Clin. Investig.
92:1412-1417.
|
| 11.
|
Donnenberg, M. S.,
J. B. Kaper, and B. B. Finlay.
1997.
Interactions between enteropathogenic Escherichia coli and host epithelial cells.
Trends Microbiol.
5:109-114[CrossRef][Medline].
|
| 12.
|
Duchmann, R.,
E. Schmitt,
P. Knolle,
K. H. Meyer zum Buschenfelde, and M. Neurath.
1996.
Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Eur. J. Immunol.
26:934-938[Medline].
|
| 13.
|
Eckmann, L.,
J. Fierer, and M. F. Kagnoff.
1996.
Genetically resistant (Ityr) and susceptible (Itys) congenic mouse strains show similar cytokine responses following infection with salmonella Dublin.
J. Immunol.
156:2894-2900[Abstract].
|
| 14.
|
Ferrante, A.
1992.
Activation of neutrophils by interleukin-1 and 2 and tumor necrosis factors.
Immunol. Ser.
57:417-436[Medline].
|
| 15.
|
Finch, P. W.,
J. S. Rubin,
T. Miki,
D. Ron, and S. A. Aaronson.
1989.
Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.
Science
245:752-755[Abstract/Free Full Text].
|
| 16.
|
Fish, S. M.,
R. Proujansky, and W. W. Reenstra.
1999.
Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function.
Gut
45:191-198[Abstract/Free Full Text].
|
| 17.
|
Frankel, G.,
A. D. Phillips,
M. Novakova,
H. Field,
D. C. Candy,
D. B. Schauer,
G. Douce, and G. Dougan.
1996.
Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter eaeA mutant: induction of an immunoglobulin A response to intimin and EspB.
Infect. Immun.
64:5315-5325[Abstract].
|
| 18.
|
Gitter, A. H.,
K. Bendfeldt,
J. D. Schulzke, and M. Fromm.
2000.
Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis.
FASEB J.
14:1749-1753[Abstract/Free Full Text].
|
| 19.
|
Higgins, L. M.,
G. Frankel,
G. Douce,
G. Dougan, and T. T. MacDonald.
1999.
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.
Infect. Immun.
67:3031-3039[Abstract/Free Full Text].
|
| 20.
|
Higgins, L. M.,
G. Frankel,
I. Connerton,
N. S. Gonçalves,
G. Dougan, and T. T. MacDonald.
1999.
Role of bacterial intimin in colonic hyperplasia and inflammation.
Science
285:588-591[Abstract/Free Full Text].
|
| 21.
|
Hodge-Dufour, J.,
M. W. Marino,
M. R. Horton,
A. Jungbluth,
M. D. Burdick,
R. M. Strieter,
P. W. Noble,
C. A. Hunter, and E. Pure.
1998.
Inhibition of interferon- induced interleukin-12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factors.
Proc. Natl. Acad. Sci. USA
94:13806-13811.
|
| 22.
|
Ihle, J. N.
1996.
STATs: signal transducers and activators of transcription.
Cell
84:331-334[CrossRef][Medline].
|
| 23.
|
Johnson, E., and S. W. Barthold.
1979.
The ultrastructure of transmissible murine colonic hyperplasia.
Am. J. Pathol.
97:291-313[Abstract].
|
| 24.
|
Jung, H. C.,
L. Eckmann,
S. K. Yang,
A. Panja,
J. Fierer,
E. Morzycka-Wroblewska, and M. F. Kagnoff.
1995.
A distinct array of proinflammatory cytokines is expressed in human colon epithelials cells in response to bacterial invasion.
J. Clin. Investig.
95:55-65.
|
| 25.
|
Klapproth, J. M.,
I. C. Scaletsky,
B. P. McNamara,
L. C. Lai,
C. Malstrom,
S. P. James, and M. S. Donnenberg.
2000.
A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation.
Infect. Immun.
68:2148-2155[Abstract/Free Full Text].
|
| 26.
|
Kollias, G.,
E. Douni,
G. Kassiotis, and D. Kontoyiannis.
1999.
The function of tumour necrosis factor in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.
Ann. Rheum. Dis.
58(Suppl. I):I32-I39.
|
| 27.
|
Kontoyiannis, D.,
M. Pasparakis,
T. T. Pizarro,
F. Cominelli, and G. Kollias.
1999.
Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.
Immunity
10:387-398[CrossRef][Medline].
|
| 28.
|
Lee, A.,
J. G. Fox,
G. Otto, and J. Murphy.
1990.
A small animal model of human Helicobacter pylori active chronic gastritis.
Gastroenterology
99:1315-1323[Medline].
|
| 29.
|
Levine, M. M.
1987.
Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.
J. Infect. Dis.
155:377-389[Medline].
|
| 30.
|
Liesenfeld, O.,
H. Kang,
D. Park,
T. A. Nguyen,
C. V. Parkhe,
H. Watanabe,
T. Abo,
A. Sher,
J. S. Remington, and Y. Suzuki.
1999.
TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii.
Parasite Immunol.
21:365-376[CrossRef][Medline].
|
| 31.
|
Liesenfeld, O.,
J. Kosek,
J. S. Remington, and Y. Suzuki.
1996.
Association of CD4+ T-cell-dependent, interferon- mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii.
J. Exp. Med.
184:597-607[Abstract/Free Full Text].
|
| 32.
|
Ma, X.,
J. Sun,
E. Papasavvas,
H. Riemann,
S. Robertson,
J. Marshall,
R. T. Bailer,
A. Moore,
R. P. Donnelly,
G. Trinchieri, and L. J. Montaner.
2000.
Inhibition of IL-12 production in human monocyte-derived macrophages by TNF.
J. Immunol.
164:1722-1729[Abstract/Free Full Text].
|
| 33.
|
MacDermott, R. P.,
I. R. Sanderson, and H. C. Reinecker.
1998.
The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease.
Inflamm. Bowel Dis.
4:54-67[Medline].
|
| 34.
|
Maini, R. N.,
M. J. Elliott,
F. M. Brennan,
R. O. Williams,
C. Q. Chu,
E. Paleolog,
P. J. Charles,
P. C. Taylor, and M. Feldmann.
1995.
Monoclonal anti-TNF- antibody as a probe of pathogenesis and therapy of rheumatoid disease.
Immunol. Rev.
144:195-223[CrossRef][Medline].
|
| 35.
|
Malaviya, R.,
T. Ikeda,
E. Ross, and S. N. Abraham.
1996.
Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF- .
Nature
381:77-80[CrossRef][Medline].
|
| 36.
|
Marchetti, M.,
B. Arico,
D. Burroni,
N. Figura,
R. Rappuoli, and P. Ghiara.
1995.
Development of a mouse model of Helicobacter pylori infection that mimics human disease.
Science
267:1655-1658[Abstract/Free Full Text].
|
| 37.
|
Marino, M. W.,
A. Dunn,
D. Grail,
M. Inglese,
Y. Noguchi,
E. Richards,
A. Jungbluth,
H. Wada,
M. Moore,
B. Williamson,
S. Basu, and L. J. Old.
1997.
Characterization of tumor necrosis factor-deficient mice.
Proc. Natl. Acad. Sci. USA
94:8093-8098[Abstract/Free Full Text].
|
| 38.
|
McDaniel, T. K.,
K. G. Jarvis,
M. S. Donnenberg, and J. B. Kaper.
1995.
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
Proc. Natl. Acad. Sci. USA
92:1664-1668[Abstract/Free Full Text].
|
| 39.
|
Mohammadi, M.,
S. Czinn,
R. Redline, and J. Nedrud.
1996.
Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice.
J. Immunol.
156:4729-4738[Abstract].
|
| 40.
|
Mulvey, M. A.,
J. D. Schilling,
J. J. Martinez, and S. J. Hultgren.
2000.
From the cover: bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
Proc. Natl. Acad. Sci. USA
97:8829-8835[Abstract/Free Full Text].
|
| 41.
|
Neurath, M. F.,
I. Fuss,
M. Pasparakis,
L. Alexopoulou,
S. Haralambous,
K. H. Meyer zum Büschenfelde,
W. Strober, and G. Kollias.
1997.
Predominant pathogenic role of tumour necrosis factor in experimental colitis in mice.
Eur. J. Immunol.
27:1743-1750[Medline].
|
| 42.
|
O'Neil, D. A.,
E. M. Porter,
D. Elewaut,
G. M. Anderson,
L. Eckmann,
T. Ganz, and M. F. Kagnoff.
1999.
Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium.
J. Immunol.
163:6718-6724[Abstract/Free Full Text].
|
| 43.
|
Panja, A.,
S. Goldberg,
L. Eckmann,
P. Krishen, and L. Mayer.
1998.
The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
J. Immunol.
161:3675-3684[Abstract/Free Full Text].
|
| 44.
|
Parrello, T.,
G. Monteleone,
S. Cucchiara,
I. Monteleone,
L. Sebkova,
P. Doldo,
F. Luzza, and F. Pallone.
2000.
Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease.
J. Immunol.
165:7234-7239[Abstract/Free Full Text].
|
| 45.
|
Pender, S. L. F.,
J. M. Fell,
S. M. Chamow,
A. Ashkenazi, and T. T. MacDonald.
1998.
A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase protection.
J. Immunol.
160:4098-4103[Abstract/Free Full Text].
|
| 46.
|
Powrie, F.,
M. W. Leach,
S. Mauze,
S. Menon,
L. B. Caddle, and R. L. Coffman.
1994.
Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.
Immunity
1:553-562[CrossRef][Medline].
|
| 47.
|
Rothbaum, R. J.,
J. C. Partin,
K. Saalfield, and A. J. McAdams.
1983.
An ultrastructural study of enteropathogenic Escherichia coli infection in human infants.
Ultrastruct. Pathol.
4:291-304[Medline].
|
| 48.
|
Salvati, V. M.,
M. Bajaj-Elliott,
R. Poulsom,
G. Mazzarella,
E. M. Nilsen,
K. E. A. Lundin,
R. Troncone, and T. T. MacDonald.
2001.
Keratinocyte growth factor in celiac disease.
Gut
49:176-181[Abstract/Free Full Text].
|
| 49.
|
Savkovic, S. D.,
A. Koutsouris, and G. Hecht.
1996.
Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils.
Infect. Immun.
64:4480-4487[Abstract].
|
| 50.
|
Schauer, D. B., and S. Falkow.
1993.
The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia.
Infect. Immun.
61:4654-4661[Abstract/Free Full Text].
|
| 51.
|
Sharief, M. K.,
M. Phil, and R. Hentges.
1991.
Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis.
N. Engl. J. Med.
325:467-472[Abstract].
|
| 52.
|
Targan, S. R.,
S. B. Hanauer,
S. J. H. van Deventer,
L. Mayer,
D. H. Present,
T. Braakman,
K. L. DeWoody,
T. F. Schaible, and P. J. Rutgeerts.
1997.
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor for Crohn's disease.
N. Engl. J. Med.
337:1029-1035[Abstract/Free Full Text].
|
| 53.
|
Tarver, A. P.,
D. P. Clark,
G. Diamond,
J. P. Russell,
H. Erdjument-Bromage,
P. Tempst,
K. S. Cohen,
D. E. Jones,
R. W. Sweeney,
M. Wines,
S. Hwang, and C. L. Bevins.
1998.
Enteric beta-defensin: molecular cloning and characterization of a gene with inducible epithelial cell expression associated with Cryptosporidium parvum infection.
Infect. Immun.
66:1045-1056[Abstract/Free Full Text].
|
| 54.
|
Trinchieri, G.
1994.
Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cells type I and cytotoxic lymphocytes.
Blood
84:4008-4027[Free Full Text].
|
| 55.
|
Vallance, B. A., and B. B. Finlay.
2000.
Exploitation of host cells by enteropathogenic Escherichia coli.
Proc. Natl. Acad. Sci. USA
97:8799-8806[Abstract/Free Full Text].
|
| 56.
|
van Deventer, S. J. H.
1997.
Tumor necrosis factor and Crohn's disease.
Gut
40:443-448[Free Full Text].
|
| 57.
|
van Dullemen, H. M.,
S. J. H. van Deventer,
D. W. Hommes,
H. A. Bijl,
J. Jansen,
G. N. J. Tytgat, and J. Woody.
1995.
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
Gastroenterology
109:129-135[CrossRef][Medline].
|
| 58.
|
Vassalli, P.
1992.
The pathophysiology of tumor necrosis factors.
Annu. Rev. Immunol.
10:411-452[CrossRef][Medline].
|
| 59.
|
Viney, J.,
T. T. MacDonald, and P. J. Kilshaw.
1989.
T cell receptor expression in intestinal intraepithelial lymphocyte subpopulations of normal and athymic mice.
Immunology
66:583-587[Medline].
|
| 60.
|
Weil, D.
1992.
What's new about tumour necrosis factors?
Eur. Cytokine Network
3:347-351[Medline].
|
Infection and Immunity, November 2001, p. 6651-6659, Vol. 69, No. 11
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.6651-6659.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dann, S. M., Spehlmann, M. E., Hammond, D. C., Iimura, M., Hase, K., Choi, L. J., Hanson, E., Eckmann, L.
(2008). IL-6-Dependent Mucosal Protection Prevents Establishment of a Microbial Niche for Attaching/Effacing Lesion-Forming Enteric Bacterial Pathogens. J. Immunol.
180: 6816-6826
[Abstract]
[Full Text]
-
Smith, A. D., Botero, S., Levander, O. A.
(2008). Copper Deficiency Increases the Virulence of Amyocarditic and Myocarditic Strains of Coxsackievirus B3 in Mice. J. Nutr.
138: 849-855
[Abstract]
[Full Text]
-
Weng, M., Huntley, D., Huang, I-F., Foye-Jackson, O., Wang, L., Sarkissian, A., Zhou, Q., Walker, W. A., Cherayil, B. J., Shi, H. N.
(2007). Alternatively Activated Macrophages in Intestinal Helminth Infection: Effects on Concurrent Bacterial Colitis. J. Immunol.
179: 4721-4731
[Abstract]
[Full Text]
-
Borenshtein, D., Nambiar, P. R., Groff, E. B., Fox, J. G., Schauer, D. B.
(2007). Development of Fatal Colitis in FVB Mice Infected with Citrobacter rodentium. Infect. Immun.
75: 3271-3281
[Abstract]
[Full Text]
-
Wiles, S., Pickard, K. M., Peng, K., MacDonald, T. T., Frankel, G.
(2006). In Vivo Bioluminescence Imaging of the Murine Pathogen Citrobacter rodentium. Infect. Immun.
74: 5391-5396
[Abstract]
[Full Text]
-
Khan, M. A., Ma, C., Knodler, L. A., Valdez, Y., Rosenberger, C. M., Deng, W., Finlay, B. B., Vallance, B. A.
(2006). Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in Mice.. Infect. Immun.
74: 2522-2536
[Abstract]
[Full Text]
-
Richardson, T. A., Sherman, M., Antonovic, L., Kardar, S. S., Strobel, H. W., Kalman, D., Morgan, E. T.
(2006). HEPATIC AND RENAL CYTOCHROME P450 GENE REGULATION DURING CITROBACTER RODENTIUM INFECTION IN WILD-TYPE AND TOLL-LIKE RECEPTOR 4 MUTANT MICE. Drug Metab. Dispos.
34: 354-360
[Abstract]
[Full Text]
-
Bry, L., Brigl, M., Brenner, M. B.
(2006). CD4+-T-Cell Effector Functions and Costimulatory Requirements Essential for Surviving Mucosal Infection with Citrobacter rodentium. Infect. Immun.
74: 673-681
[Abstract]
[Full Text]
-
Chen, C.-C., Louie, S., McCormick, B. A., Walker, W. A., Shi, H. N.
(2006). Helminth-Primed Dendritic Cells Alter the Host Response to Enteric Bacterial Infection. J. Immunol.
176: 472-483
[Abstract]
[Full Text]
-
Zakharova, M., Ziegler, H. K.
(2005). Paradoxical Anti-Inflammatory Actions of TNF-{alpha}: Inhibition of IL-12 and IL-23 via TNF Receptor 1 in Macrophages and Dendritic Cells. J. Immunol.
175: 5024-5033
[Abstract]
[Full Text]
-
Chen, C.-C., Louie, S., McCormick, B., Walker, W. A., Shi, H. N.
(2005). Concurrent Infection with an Intestinal Helminth Parasite Impairs Host Resistance to Enteric Citrobacter rodentium and Enhances Citrobacter-Induced Colitis in Mice. Infect. Immun.
73: 5468-5481
[Abstract]
[Full Text]
-
Bruno, M. E. C., Kaetzel, C. S.
(2005). Long-Term Exposure of the HT-29 Human Intestinal Epithelial Cell Line to TNF Causes Sustained Up-Regulation of the Polymeric Ig Receptor and Proinflammatory Genes through Transcriptional and Posttranscriptional Mechanisms. J. Immunol.
174: 7278-7284
[Abstract]
[Full Text]
-
Iimura, M., Gallo, R. L., Hase, K., Miyamoto, Y., Eckmann, L., Kagnoff, M. F.
(2005). Cathelicidin Mediates Innate Intestinal Defense against Colonization with Epithelial Adherent Bacterial Pathogens. J. Immunol.
174: 4901-4907
[Abstract]
[Full Text]
-
Wei, O. L., Hilliard, A., Kalman, D., Sherman, M.
(2005). Mast Cells Limit Systemic Bacterial Dissemination but Not Colitis in Response to Citrobacter rodentium. Infect. Immun.
73: 1978-1985
[Abstract]
[Full Text]
-
Savkovic, S. D., Villanueva, J., Turner, J. R., Matkowskyj, K. A., Hecht, G.
(2005). Mouse Model of Enteropathogenic Escherichia coli Infection. Infect. Immun.
73: 1161-1170
[Abstract]
[Full Text]
-
Ramirez, K., Huerta, R., Oswald, E., Garcia-Tovar, C., Hernandez, J. M., Navarro-Garcia, F.
(2005). Role of EspA and Intimin in Expression of Proinflammatory Cytokines from Enterocytes and Lymphocytes by Rabbit Enteropathogenic Escherichia coli-Infected Rabbits. Infect. Immun.
73: 103-113
[Abstract]
[Full Text]
-
Li, C. K. F., Pender, S. L. F., Pickard, K. M., Chance, V., Holloway, J. A., Huett, A., Goncalves, N. S., Mudgett, J. S., Dougan, G., Frankel, G., MacDonald, T. T.
(2004). Impaired Immunity to Intestinal Bacterial Infection in Stromelysin-1 (Matrix Metalloproteinase-3)-Deficient Mice. J. Immunol.
173: 5171-5179
[Abstract]
[Full Text]
-
KELLY, P., MENZIES, I., CRANE, R., ZULU, I., NICKOLS, C., FEAKINS, R., MWANSA, J., MUDENDA, V., KATUBULUSHI, M., GREENWALD, S., FARTHING, M.
(2004). RESPONSES OF SMALL INTESTINAL ARCHITECTURE AND FUNCTION OVER TIME TO ENVIRONMENTAL FACTORS IN A TROPICAL POPULATION. Am J Trop Med Hyg
70: 412-419
[Abstract]
[Full Text]
-
Spahn, T W, Kucharzik, T
(2004). Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut
53: 456-465
[Full Text]
-
Simmons, C. P., Clare, S., Ghaem-Maghami, M., Uren, T. K., Rankin, J., Huett, A., Goldin, R., Lewis, D. J., MacDonald, T. T., Strugnell, R. A., Frankel, G., Dougan, G.
(2003). Central Role for B Lymphocytes and CD4+ T Cells in Immunity to Infection by the Attaching and Effacing Pathogen Citrobacter rodentium. Infect. Immun.
71: 5077-5086
[Abstract]
[Full Text]
-
Vallance, B. A., Deng, W., Jacobson, K., Finlay, B. B.
(2003). Host Susceptibility to the Attaching and Effacing Bacterial Pathogen Citrobacter rodentium. Infect. Immun.
71: 3443-3453
[Abstract]
[Full Text]